The London Clinic, a large private hospital in London, is opening a new diagnostics centre just across from its main site in Harley Street, London, to deliver fast diagnostics services to patients wanting to skip NHS queues.
Pharmacists in the UK now have the right to prescribe for common ailments such as sore throats and earaches. In France, Ireland and Portugal pharmacists also have some prescribing rights and similar initiatives may be introduced in other European countries in the near future. Is this a solution to the GP workforce shortage? And will it be a good thing for private hospital and private primary care groups?
Have public-private partnerships had their day? Who better to answer this than Alberto de Rosa, president of Spanish hospital group Ribera Salud which was forced to pivot away from PPPs to fight off political opposition, and meet the demands of a shifting Spanish healthcare environment. HBI asks him how the model, in any form, might survive.
A shortage of high-quality healthcare workers in Europe is causing countries to recruit from a more global pool. The Danish government is partnering with India and the Philippines, and HBI hears LATAM could be the new hotspot from which foreign workers will be enlisted in future.
UK hospital operator Spire has opened its 20th London GP clinic, one of at least five opened this year. Does this bode well for the state of the UK primary care market?
Primary care group Operose is being sold to HCRG Care Group, a UK healthcare provider. It is the last of the three major Europe-based groups to be sold off by US insurance company Centene.
This week, the UK’s Home Secretary James Cleverly announced government plans to tighten health and care worker visas. HBI speaks to a global workforce expert to understand what this attempt to prioritise ‘British talent first’ will mean for operators already facing a workforce crisis.
Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary.
Value health is a key proposition in the Saudi 2030 transformation plan. But previous attempts in other markets have met with questionable results. What exactly does value health mean in this burgeoning market - and how is this set to change payor-operator contracts?
HBI speaks to Nabil Fawaz, sector manager for World Bank member MIGA. MIGA promotes cross border investment in developing countries by providing guarantees (political risk insurance and credit enhancement) to investors and lenders in sectors including healthcare.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy